| Filed On | Filing |
|---|---|
| 22 Jul 2026 |
Form 3: Silber Jeffrey, SVP, CMO, Head-Res&Drug
No securities owned |
| 21 Mar 2025 |
Form 3: Gaskins Tammi L, Chief Commercial Officer
Holds 245,159 shares of Class A Common Stock |
| 29 Jan 2025 |
Form 3: Martini Gregory S., Chief Financial Officer
Holds 84,751 shares of Class A Common Stock |
| 08 Jun 2022 |
Form 3: Davis Andrew, SVP, Chief Business Officer
Holds 156,516 shares of Class A Common Stock |
| 08 Dec 2021 |
Form 3: Emany Sravan Kumar, SVP, Chief Financial Officer
No securities owned |
| 04 Aug 2021 |
Form 3: John Minardo, Chief Legal Officer
No securities owned |
| 22 Jul 2021 |
Form 3: Silver Ronald, Principal Accounting Officer
Holds 43,242 shares of Class A Common Stock |
| 03 Dec 2020 |
Form 3: Shepard Jay, Director
No securities owned |
| 09 Nov 2020 |
Form 3: Denner Alexander J, Director
Holds 14,040,000 shares of Class A Common Stock |
| 21 Apr 2020 |
Form 3: Shetzline Michael, CMO, SVP & Head of Drug Devt.
Holds 86,306 shares of Class A Common Stock |
| 21 Apr 2020 |
Form 3: Rickard Jason, SVP, Chief Operating Officer
Holds 235,090 shares of Class A Common Stock |
| 21 Apr 2020 |
Form 3: Kilroy Conor, SVP, GC & Secretary
Holds 106,823 shares of Class A Common Stock |
| 11 Jul 2019 |
Form 3: MacDonald Kelly, Chief Accounting Officer
Holds 71,824 shares of Class A Common Stock |
| 03 Apr 2019 |
Form 3: Moukheibir Catherine, Director
No securities owned |
| 03 Apr 2019 |
Form 3: Kessler Marla L, Director
No securities owned |
| 03 Apr 2019 |
Form 3: Duane Jon R, Director
No securities owned |
| 14 Mar 2019 |
Form 3: Fanucci Marsha, Director
No securities owned |
| 14 Mar 2019 |
Form 3: Ironwood Pharmaceuticals Inc, 10% owner · Korsana Biosciences, Inc.
Holds 100 shares of Common Stock |
| 11 Jan 2019 |
Form 3: Mallon Mark, Executive Senior Advisor
No securities owned |
| 19 Dec 2017 |
Form 3: Huyett William, Chief Operating Officer
No securities owned |
Loading...
